Allspring Global Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Allspring Global Investments's BIIB Position: Q2 2026 in Review
Allspring Global Investments increased its Biogen (BIIB) stake by 2% in Q2 2026, buying an estimated $28.5K and bringing the position to 7,471 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1120.
Allspring Global Investments first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. The position peaked at $27.9M in Q4 2022. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Allspring Global Investments held 7,471 shares of Biogen worth $1.57M as of Q2 2026.
- Allspring Global Investments bought 149 Biogen shares in Q2 2026, an estimated $28.5K.
- Biogen made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1120 holding.
- Allspring Global Investments first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's Biogen position peaked at $27.9M in Q4 2022.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.